Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight brokerages that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating, two have assigned a buy rating and two have given a strong buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $2.50.
CRLBF has been the subject of several recent research reports. Atb Cap Markets lowered shares of Cresco Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, December 9th. Cormark downgraded Cresco Labs from a "moderate buy" rating to a "hold" rating in a report on Monday, November 11th. Finally, Roth Capital upgraded Cresco Labs to a "strong-buy" rating in a report on Sunday, November 10th.
Read Our Latest Report on CRLBF
Cresco Labs Trading Up 3.7 %
OTCMKTS CRLBF traded up $0.04 during trading on Tuesday, hitting $1.01. The company had a trading volume of 695,652 shares, compared to its average volume of 733,813. The company's fifty day moving average is $1.12 and its 200-day moving average is $1.46. The company has a market cap of $493.02 million, a price-to-earnings ratio of -5.05 and a beta of 1.79. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a one year low of $0.78 and a one year high of $2.65.
Cresco Labs Company Profile
(
Get Free ReportCresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Read More
Before you consider Cresco Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.
While Cresco Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
